Cost-effectiveness analysis results: asymptomatic patient population subanalysisa
| Strategy | Cost ($) | Incremental Cost ($) | Effectiveness (QALYs) | Incremental Effectiveness (QALYs) | Incremental Cost-Effectiveness Ratio ($/QALY) |
|---|---|---|---|---|---|
| CTAP | 145,247 | – | 13.86 | – | |
| TCD | 156,272 | 11,024 | 13.51 | −0.3517 | Dominated |
↵a CTAP imaging strategy is used as the reference in the incremental cost-effectiveness results.